Company intelligence / Profile preview

Vyta

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Vyta is a longevity science company dedicated to extending human healthspan through personalized biological insights and evidence-based interventions. The company provides advanced biological age testing using epigenetic clocks to help individuals understand their rate of aging at a cellular level. Based on these diagnostics, Vyta offers a curated ecosystem of longevity supplements and lifestyle protocols designed to optimize metabolic, cognitive, and cellular health. By combining diagnostic data with targeted nutraceuticals, Vyta aims to bridge the gap between longevity research and consumer health applications.

Therapeutic areas: NeurologyOtherMetabolic Disorders
Modalities: Small moleculePeptidesNutraceuticals
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Vyta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vyta.

Explore the full profile